Back to the Mental Health Monitor
GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care
Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care
Video & Information Sheet assets
Photo gallery
Michele Long (left) is a primary care nurse practitioner who makes a point of screening for depression and discussing mental health with all of her patients. The GeneSight Mental Health Monitor finds that more than half of primary care physicians surveyed believe their patients are unaware that they are trained and equipped to diagnose and treat mental health conditions.
As a primary care provider, Michele Long makes a point to screen every patient for mental health conditions. Long uses the GeneSight test to make informed decisions about mental health medications and doses that may be more likely to be effective for a patient based on their genetic information.
The GeneSight test helps providers make decisions on mental health medications and doses that may be more likely to help patients suffering from anxiety, depression, ADHD and other mental health conditions based on their unique genetic information.
Michele Long (right) reviews a GeneSight test report with her patient, Beth. Genetic information helps providers find effective mental health medications and may reduce the frustrating trial-and-error process that is common when treating mental illness.
Michele Long conducts a GeneSight test on a patient diagnosed with depression. With a simple cheek swab, the test provides clinicians with a patient’s unique genetic information that indicates which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects.
The GeneSight Mental Health Monitor is a nationwide survey of U.S. adults conducted online by ACUPOLL Precision Research, Inc. from Aug. 16 – 30, 2022, among a statistically representative sample (n=1000) of adults age 18+. The survey included a representative sample of women diagnosed with depression and anxiety. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.